Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 50 results.
User Information
Export Records
  1. 1.   Interim Analysis: Open-Label Extension Study of Leniolisib for Patients with APDS
  2. Rao, V Koneti; Kulm,Elaine; Šedivá, Anna; Plebani, Alessandro; Schuetz, Catharina; Shcherbina, Anna; Dalm, Virgil A; Trizzino, Antonino; Zharankova, Yulia; Webster, Sharon; Orpia, Alanvin; Körholz, Julia; Lougaris, Vassilios; Rodina, Yulia; Radford, Kath; Bradt, Jason; Relan, Anurag; Holland, Steven M; Lenardo, Michael J; Uzel, Gulbu
  3. The Journal of Allergy and clinical immunology.. 2023, Oct 03;
  1. 2.   Nanocomplexes of doxorubicin and DNA fragments for efficient and safe cancer chemotherapy
  2. Mohammad, Saad N; Choi, Yeon Su; Chung, Jee Young; Cedrone,Edward; Neun,Barry; Dobrovolskaia,Marina; Yang, Xiaojing; Guo, Wei; Chew, Yap Ching; Kim, Juwan; Baek, Seunggul; Kim, Ik Soo; Fruman, David A; Kwon, Young Jik
  3. Journal of Controlled Release : official journal of the Controlled Release Society. 2023, Jan; 354: 91-108.
  1. 3.   Adcitmer(R), a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma
  2. Esnault, C.; Martin, C.; Desgranges, A.; Baltus, C. B.; Aubrey, N.; Lakhrif, Z.; Lajoie, L.; Lantier, L.; Clemenceau, B.; Sarma, B.; Schrama, J.; Houben, R.; Schrama, D.; Hesbacher, S.; Feng,Yang; Dimitrov, D.; Guyetant, S.; Berthon, P.; Viaud-Massuard, M. C.; Samimi, M.; Touze, A.; Kervarrec, T.
  3. The British Journal of Dermatology. 2021, Sep 28;
  1. 4.   Distinct Biomarker Profiles and TCR Sequence Diversity Characterize the Response to PD-L1 Blockade in a Mouse Melanoma Model
  2. El Meskini,Rajaa; Atkinson,Devon; Kulaga, Alan; Abdelmaksoud,Abdalla; Gumprecht, Michelle; Pate, Nathan; Hayes, Susana; Oberst, Michael; Kaplan, Ian M.; Raber, Patrick; Van Dyke, Terry; Sharan,Shyam; Hollingsworth, Robert; Day, Chi-Ping; Merlino, Glenn; Ohler,Zoe
  3. Molecular cancer research : MCR. 2021, Aug 1; 19(8): 1422-1436.
  1. 5.   The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines
  2. Condit, Richard C; Kim, Denny; Robertson, James S; Excler, Jean-Louis; Gurwith, Marc; Monath, Thomas P; Pavlakis,George; Fast, Patricia E; Smith, Jonathan; Smith, Emily R; Chen, Robert T; Kochhar, Sonali
  3. Vaccine. 2020, NOV 17; 38(49): 7708-7715.
  1. 6.   The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines
  2. Condit, Richard C; Kim, Denny; Robertson, James S; Excler, Jean-Louis; Gurwith, Marc; Monath, Thomas P; Pavlakis,George; Fast, Patricia E; Smith, Jonathan; Smith, Emily R; Chen, Robert T; Kochhar, Sonali
  3. Vaccine. 2020, Sep 06; pii: S0264-410X(20)31030-6.
  1. 7.   The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines
  2. Condit, Richard C; Kim, Denny; Robertson, James S; Excler, Jean-Louis; Gurwith, Marc; Monath, Thomas P; Pavlakis,George; Fast, Patricia E; Smith, Jonathan; Smith, Emily R; Chen, Robert T; Kochhar, Sonali
  3. Vaccine. 2020, Sep 06; pii: S0264-410X(20)31030-6.
  1. 8.   Safety and Stability of Antibody-Dye Conjugate in Optical Molecular Imaging
  2. Pei, Jacqueline; Juniper, Georgina; van den Berg, Nynke S.; Nisho, Naoki; Broadt,Trevor; Welch,Anthony; Yi, Grace S.; Raymundo, Roan C.; Chirita, Stefania U.; Lu, Guolan; Krishnan, Giri; Lee, Yu-Jin; Kapoor, Shrey; Zhou, Quan; Colevas, A. Dimitrios; Lui, Natalie S.; Poultsides, George A.; Li, Gordon; Zinn, Kurt R.; Rosenthal, Eben L.
  3. MOLECULAR IMAGING AND BIOLOGY. 2020, SEP 3;
  1. 9.   Detection of Beta-Glucan Contamination in Nanotechnology-Based Formulations
  2. Neun,Barry; Cedrone,Edward; Potter, Timothy M.; Crist,Rachael; Dobrovolskaia,Marina
  3. Molecules (Basel, Switzerland). 2020, AUG; 25(15):
  1. 10.   The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines
  2. Kim, Denny; Robertson, James S.; Excler, Jean-Louis; Condit, Richard C.; Fast, Patricia E.; Gurwith, Marc; Pavlakis,George; Monath, Thomas P.; Smith, Jonathan; Wood, David; Smith, Emily R.; Chen, Robert T.; Kochhar, Sonali
  3. Vaccine. 2020, JUL 22; 38(34): 5556-5561.
  1. 11.   Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
  2. Ou, Li; Kong, Wing-Pui; Chuang, Gwo-Yu; Ghosh, Mridul; Gulla, Krishana; O'Dell, Sijy; Varriale, Joseph; Barefoot, Nathan; Changela, Anita; Chao, Cara W; Cheng, Cheng; Druz, Aliaksandr; Kong, Rui; McKee, Krisha; Rawi, Reda; Sarfo, Edward K; Schön, Arne; Shaddeau, Andrew; Tsybovsky,Yaroslav; Verardi, Raffaello; Wang, Shuishu; Wanninger, Timothy G; Xu, Kai; Yang, Gengcheng J; Zhang, Baoshan; Zhang, Yaqiu; Zhou, Tongqing; Arnold, Frank J; Doria-Rose, Nicole A; Lei, Q Paula; Ryan, Edward T; Vann, Willie F; Mascola, John R; Kwong, Peter D
  3. Scientific reports. 2020, Feb 20; 10(1): 3032.
  1. 12.   Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections
  2. Logue, James; Crozier,Ian; Jahrling, Peter B; Kuhn, Jens H
  3. Expert review of vaccines. 2020, Jan 15; 19(1): 85-103.
  1. 13.   Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies
  2. Dobrovolskaia,Marina
  3. Molecules (Basel, Switzerland). 2019, Dec; 24(24):
  1. 14.   A Phase II Trial of Vandetanib in Children and Adults with Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor
  2. Glod, John; Arnaldez, Fernanda I.; Wiener, Lori; Spencer, Melissa; Killian, J. Keith; Meltzer, Paul; Dombi, Eva; Derse-Anthony, Claudia; Derdak, Joanne; Srinivasan, Ramaprasad; Linehan, W. Marston; Miettinen, Markku; Steinberg, Seth M.; Helman, Lee; Widemann, Brigitte C.
  3. CLINICAL CANCER RESEARCH. 2019, Nov 1; 25: 6302-6308.
  1. 15.   Report on the 2018 Cancer, Autoimmunity, and Immunology Conference
  2. Curran, Colleen S.; Sommers, Connie L.; Young,Howard; Bourcier, Katarzyna; Mancini, Marie; Sharon, Elad
  3. Journal of immunology (Baltimore, Md. : 1950). 2019, May 15; 202(10): 2823-2828.
  1. 16.   Anticoagulants Influence the Performance of In Vitro Assays Intended for Characterization of Nanotechnology-Based Formulations
  2. Cedrone, Edward; Neun, Barry; Rodriguez, Jamie; Vermilya, Alison; Clogston, Jeffrey; McNeil, Scott; Barenholz, Yechezkel; Szebeni, Janos; Dobrovolskaia, Marina
  3. Molecules . 2018, Jan; 23(1): pii: E12.
  1. 17.   Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity
  2. Scott, Jack D.; DeMong, Duane E.; Greshock, Thomas J.; Basu, Kallol; Dai, Xing; Harris, Joel; Hruza, Alan; Li, Sarah W.; Lin, Sue-Ing; Liu, Hong; Macala, Megan K.; Hu, Zhiyong; Mei, Hong; Zhang, Honglu; Walsh, Paul; Poirier, Marc; Shi, Zhi-Cai; Xiao, Li; Agnihotri, Gautam; Baptista, Marco A. S.; Columbus, John; Fell, Matthew J.; Hyde, Lynn A.; Kuvelkar, Reshma; Lin, Yinghui; Mirescu, Christian; Morrow, John A.; Yin, Zhizhang; Zhang, Xiaoping; Zhou, Xiaoping; Chang, Ronald K.; Embrey, Mark W.; Sanders, John M.; Tiscia, Heather E.; Drolet, Robert E.; Kern, Jonathan T.; Sur, Sylvie M.; Renger, John J.; Bilodeau, Mark T.; Kennedy, Matthew E.; Parker, Eric M.; Stamford, Andrew W.; Nargund, Ravi; McCauley, John A.; Miller, Michael W.
  3. JOURNAL OF MEDICINAL CHEMISTRY. 2017, 2017-04-13; 60(7): 2983-2992.
  1. 18.   Population pharmacokinetic analysis of sorafenib in patients with solid tumours
  2. Jain, L.; Woo, S.; Gardner, E. R.; Dahut, W. L.; Kohn, E. C.; Kummar, S.; Mould, D. R.; Giaccone, G.; Yarchoan, R.; Venitz, J.; Figg, W. D.
  3. British Journal of Clinical Pharmacology. 2011, Aug; 72(2): 294-305.
  1. 19.   Prevalence of Etravirine-Associated Mutations in Clinical Samples With Genotypic Resistance to Nevirapine and Efavirenz in Brazilian Clinics
  2. Martins, A. N.; Arruda, M. B.; Aleixo, A. W.; Pires, A. F.; Greco, D. B.; Brindeiro, R. D.; Tanuri, A.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2011, Aug; 57: S193-S196.
  1. 20.   A Single Polymorphism in HIV-1 Subtype C SP1 Is Sufficient To Confer Natural Resistance to the Maturation Inhibitor Bevirimat
  2. Lu, W. X.; Salzwedel, K.; Wang, D.; Chakravarty, S.; Freed, E. O.; Wild, C. T.; Li, F.
  3. Antimicrobial Agents and Chemotherapy. 2011, Jul; 55(7): 3324-3329.
  1. 21.   Interlaboratory comparison of size and surface charge measurements on nanoparticles prior to biological impact assessment
  2. Roebben, G.; Ramirez-Garcia, S.; Hackley, V. A.; Roesslein, M.; Klaessig, F.; Kestens, V.; Lynch, I.; Garner, C. M.; Rawle, A.; Elder, A.; Colvin, V. L.; Kreyling, W.; Krug, H. F.; Lewicka, Z. A.; McNeil, S.; Nel, A.; Patri, A.; Wick, P.; Wiesner, M.; Xia, T.; Oberdorster, G.; Dawson, K. A.
  3. Journal of Nanoparticle Research. 2011, Jul; 13(7): 2675-2687.
  1. 22.   A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
  2. Ledgerwood, J. E.; Pierson, T. C.; Hubka, S. A.; Desai, N.; Rucker, S.; Gordon, I. J.; Enama, M. E.; Nelson, S.; Nason, M.; Gu, W. J.; Bundrant, N.; Koup, R. A.; Bailer, R. T.; Mascola, J. R.; Nabel, G. J.; Graham, B. S.; Team, V. R. C. S.
  3. Journal of Infectious Diseases. 2011, May; 203(10): 1396-1404.
  1. 23.   Anti-HIV microbicide development: targeting the virus is the key
  2. O'Keefe, B. R.
  3. Future Virology. 2011, May; 6(5): 553-556.
  1. 24.   A Rapid Flp-In System for Expression of Secreted H5N1 Influenza Hemagglutinin Vaccine Immunogen in Mammalian Cells
  2. Lu, H. X.; Khurana, S.; Verma, N.; Manischewitz, J.; King, L.; Beigel, J. H.; Golding, H.
  3. Plos One. 2011, Feb; 6(2): 8.
  1. 25.   Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals
  2. Ho, J.; Moir, S.; Wang, W.; Posada, J. G.; Gu, W. J.; Rehman, M. T.; Dewar, R.; Kovacs, C.; Sneller, M. C.; Chun, T. W.; Follmann, D. A.; Fauci, A. S.
  3. Aids. 2011, Jan; 25(3): 295-302.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel